Galileo is a healthcare startup founded in 2018 with the mission to improve the quality and affordability of healthcare across the United States. Led by Dr. Tom X. Lee, a pioneer in the healthcare industry, Galileo offers high-touch, data-driven, multi-specialty, longitudinal care to diverse and complex patients. The startup has gained the trust of regional and national health plans, employers, and Fortune 500 organizations as the leading solution to improve population health.
Operating across 50 states, Galileo is backed by a $114.89K Venture Round investment led by Gaingels on 12 April 2023. With a team comprising leading innovators from healthcare, technology, and human-centered design, Galileo aims to solve the largest healthcare problems while enhancing the patient-provider relationship.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $114.89K | 1 |
|
12 Apr 2023 |
| Series D | Unknown | 5 |
|
07 Dec 2022 |
| Secondary Market | Unknown | - | 01 Jul 2022 | |
| Series C | Unknown | 2 |
|
23 Feb 2021 |
| Series B | Unknown | 2 |
|
09 Jun 2020 |
No recent news or press coverage available for Galileo .
We care about your data, and we'd love to use cookies make your experience better.
